Acute pneumonia and the cardiovascular system

The Lancet

Volumn 381, Issue 9865, 2013, Pages 496-505

  Corrales Medina, Vicente F ^a,b   Musher, Daniel M ^c,d   Shachkina, Svetlana ^a,b   Chirinos, Julio A ^e,f  

^a UNIVERSITY OF OTTAWA   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMOXICILLIN; ANGIOTENSIN RECEPTOR ANTAGONIST; AZITHROMYCIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA LACTAM ANTIBIOTIC; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; TROPONIN; VANCOMYCIN; VASODILATOR AGENT;

BLOOD CLOTTING; CARDIOVASCULAR DISEASE; ERYTHEMA; FLUID INTAKE; HEART ARRHYTHMIA; HEART FAILURE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPOTENSION; HYPOXEMIA; KIDNEY FUNCTION; LOBAR PNEUMONIA; LOW DRUG DOSE; MORTALITY; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; PRURITUS; QT PROLONGATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SODIUM BALANCE; VASCULAR ENDOTHELIUM;

EID: 84873728481     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(12)61266-5     Document Type: Review

References (100)

1. LA Mandell, RG Wunderink, A Anzueto et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults Clin Infect Dis 44 suppl 2 2007 S27 S72
2. TM File Jr, TJ Marrie Burden of community-acquired pneumonia in North American adults Postgrad Med 122 2010 130 141
3. AD Lopez, CD Mathers, M Ezzati, DT Jamison, CJ Murray Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data Lancet 367 2006 1747 1757
4. T Welte, A Torres, D Nathwani Clinical and economic burden of community-acquired pneumonia among adults in Europe Thorax 67 2012 71 79
5. J Leal, R Luengo-Fernandez, A Gray, S Petersen, M Rayner Economic burden of cardiovascular diseases in the enlarged European Union Eur Heart J 27 2006 1610 1619
6. VL Roger, AS Go, DM Lloyd-Jones et al. Heart disease and stroke statistics - 2011 update: a report from the American Heart Association Circulation 123 2011 e18 209
7. WS Lim, SV Baudouin, RC George et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009 Thorax 64 suppl 3 2009 iii1 ii55
8. AM Fry, DK Shay, RC Holman, AT Curns, LJ Anderson Trends in hospitalizations for pneumonia among persons aged 65 years or older in the United States, 1988-2002 JAMA 294 2005 2712 2719
9. VF Corrales-Medina, DM Musher, GA Wells, JA Chirinos, L Chen, MJ Fine Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality Circulation 125 2012 773 781
10. AU Khand, I Gemmell, AC Rankin, JG Cleland Clinical events leading to the progression of heart failure: insights from a national database of hospital discharges Eur Heart J 22 2001 153 164
11. VF Corrales-Medina, M Madjid, DM Musher Role of acute infection in triggering acute coronary syndromes Lancet Infect Dis 10 2010 83 92
12. A Singanayagam, DH Elder, JD Chalmers Is community-acquired pneumonia an independent risk factor for cardiovascular disease? Eur Respir J 39 2012 187 196
13. O Vardeny, NK Sweitzer, MA Detry, JM Moran, MR Johnson, MS Hayney Decreased immune responses to influenza vaccination in patients with heart failure J Card Fail 15 2009 368 373
14. CG Harford, MN Hara Effect of pulmonary edema on susceptibility of mice to pneumococcal pneumonia Proc Annu Meet Cent Soc Clin Res US 20 1947 15
15. FM LaForce, JF Mullane, RF Boehme, WJ Kelly, GL Huber The effect of pulmonary edema on antibacterial defenses of the lung J Lab Clin Med 82 1973 634 648
16. I Koivula, M Sten, PH Makela Risk factors for pneumonia in the elderly Am J Med 96 1994 313 320
17. M Dong, T Liu, G Li Association between acute infections and risk of acute coronary syndrome: a meta-analysis Int J Cardiol 147 2011 479 482
18. A Baylin, S Hernandez-Diaz, X Siles, EK Kabagambe, H Campos Triggers of nonfatal myocardial infarction in Costa Rica: heavy physical exertion, sexual activity, and infection Ann Epidemiol 17 2007 112 118
19. DM Musher, AM Rueda, AS Kaka, SM Mapara The association between pneumococcal pneumonia and acute cardiac events Clin Infect Dis 45 2007 158 165
20. VF Corrales-Medina, KN Suh, G Rose et al. Cardiac complications in patients with community-acquired pneumonia: a systematic review and meta-analysis of observational studies PLoS Med 8 2011 e1001048
21. TJ Marrie, MR Shariatzadeh Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study Medicine (Baltimore) 86 2007 103 111
22. VF Corrales-Medina, J Serpa, AM Rueda et al. Acute bacterial pneumonia is associated with the occurrence of acute coronary syndromes Medicine (Baltimore) 88 2009 154 159
23. J Ramirez, S Aliberti, M Mirsaeidi et al. Acute myocardial infarction in hospitalized patients with community-acquired pneumonia Clin Infect Dis 47 2008 182 187
24. GE Carr, TC Yuen, JF McConville et al. Early cardiac arrest in patients hospitalized with pneumonia: a report from the American Heart Association's Get With the Guidelines - Resuscitation Program Chest 141 2012 1528 1536
25. S Aliberti, A Amir, P Peyrani et al. Incidence, etiology, timing, and risk factors for clinical failure in hospitalized patients with community-acquired pneumonia Chest 134 2008 955 962
26. EM Mortensen, CM Coley, DE Singer et al. Causes of death for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team cohort study Arch Intern Med 162 2002 1059 1064
27. H Jasti, EM Mortensen, DS Obrosky, WN Kapoor, MJ Fine Causes and risk factors for rehospitalization of patients hospitalized with community-acquired pneumonia Clin Infect Dis 46 2008 550 556
28. DW Landry, JA Oliver The pathogenesis of vasodilatory shock N Engl J Med 345 2001 588 595
29. JD Hunter, M Doddi Sepsis and the heart Br J Anaesth 104 2010 3 11
30. J John, DB Woodward, Y Wang et al. Troponin-I as a prognosticator of mortality in severe sepsis patients J Crit Care 25 2010 270 275
31. H Schmidt, U Muller-Werdan, T Hoffmann et al. Autonomic dysfunction predicts mortality in patients with multiple organ dysfunction syndrome of different age groups Crit Care Med 33 2005 1994 2002
32. MJ Schultz, JJ Haitsma, H Zhang, AS Slutsky Pulmonary coagulopathy as a new target in therapeutic studies of acute lung injury or pneumonia - a review Crit Care Med 34 2006 871 877
33. C Chelazzi, G Villa, AR De Gaudio Cardiorenal syndromes and sepsis Int J Nephrol 2011 2011 652967
34. T Dremsizov, G Clermont, JA Kellum, KG Kalassian, MJ Fine, DC Angus Severe sepsis in community-acquired pneumonia: when does it happen, and do systemic inflammatory response syndrome criteria help predict course? Chest 129 2006 968 978
35. BI Gel'tser, TA Brodskaia Functional condition of the vascular endothelium in patients with extrahospital pneumonia Klin Med (Mosk) 83 2005 19 24 [in Russian].
36. EV Ermakov, GP Ostapenko Characteristics of hemodynamic disorders in young patients with viral-bacterial pneumonia Ter Arkh 56 1984 103 108 [in Russian].
37. H Benson, M Akbarian, LN Adler, WH Abelmann Hemodynamic effects of pneumonia. I. Normal and hypodynamic responses J Clin Invest 49 1970 791 798
38. R Kumar, WA Wallace, A Ramirez, H Benson, WH Abelmann Hemodynamic effects of pneumonia. II. Expansion of plasma volume J Clin Invest 49 1970 799 805
39. EV Ermakov, GP Ostapenko Hemodynamics in viral-bacterial pneumonia in middle-aged patients Ter Arkh 59 1987 84 88 [in Russian].
40. P Schuetz, M Christ-Crain, W Zimmerli, B Mueller Repeated measurements of endothelin-1 precursor peptides predict the outcome in community-acquired pneumonia Intensive Care Med 37 2011 970 980
41. P Schuetz, M Wolbers, M Christ-Crain et al. Prohormones for prediction of adverse medical outcome in community-acquired pneumonia and lower respiratory tract infections Crit Care 14 2010 R106
42. VK Gavrisiuk, AI Iachnik, AP Diachenko Correction of hemodynamics in patients with acute pneumonia Ter Arkh 59 1987 92 94 [in Russian].
43. O Saphir, GD Amromin Myocarditis in instances of pneumonia Ann Intern Med 28 1948 963 970
44. O Yetkin, SS Hacievliyagil, H Gunen Assessment of B-type natriuretic peptide in patients with pneumonia Int J Clin Pract 62 2008 488 491
45. C Prat, A Lacoma, J Dominguez et al. Midregional pro-atrial natriuretic peptide as a prognostic marker in pneumonia J Infect 55 2007 400 407
46. M Christ-Crain, T Breidthardt, D Stolz et al. Use of B-type natriuretic peptide in the risk stratification of community-acquired pneumonia J Intern Med 264 2008 166 176
47. MQ Moammar, MI Ali, NA Mahmood, VA DeBari, MA Khan Cardiac troponin I levels and alveolar-arterial oxygen gradient in patients with community-acquired pneumonia Heart Lung Circ 19 2010 90 92
48. KJ Thomson, DD Rustein Electrocardiographic studies during and after pneumococcus pneumonia Am Heart J 31 1946 565 579
49. MA Seedat, C Feldman, J Skoularigis, DA Promnitz, C Smith, S Zwi A study of acute community-acquired pneumonia, including details of cardiac changes Q J Med 86 1993 669 675
50. M Naghavi, P Wyde, S Litovsky et al. Influenza infection exerts prominent inflammatory and thrombotic effects on the atherosclerotic plaques of apolipoprotein E-deficient mice Circulation 107 2003 762 768
51. M Haidari, PR Wyde, S Litovsky et al. Influenza virus directly infects, inflames, and resides in the arteries of atherosclerotic and normal mice Atherosclerosis 208 2010 90 96
52. M Madjid, D Vela, H Khalili-Tabrizi, SW Casscells, S Litovsky Systemic infections cause exaggerated local inflammation in atherosclerotic coronary arteries: clues to the triggering effect of acute infections on acute coronary syndromes Tex Heart Inst J 34 2007 11 18
53. MM Birck, E Pesonen, M Odermarsky et al. Infection-induced coronary dysfunction and systemic inflammation in piglets are dampened in hypercholesterolemic milieu Am J Physiol Heart Circ Physiol 300 2011 H1595 H1601
54. IV Maev, LA Merzlikin, AN Kaziulin, LP Vorob'ev Doppler echocardiographic assessment of pulmonary blood flow in patients with acute pneumonia Ter Arkh 63 1991 30 33 [in Russian].
55. M Vassallo, SC Allen A study of autonomic cardiovascular reflexes in elderly patients with pneumonia Int J Clin Pract 51 1997 438 441
56. EB Milbrandt, MC Reade, M Lee et al. Prevalence and significance of coagulation abnormalities in community-acquired pneumonia Mol Med 15 2009 438 445
57. K Ogata, K Yagawa, S Hayashi et al. Thrombosis-inducing activity in plasma of patients with acute respiratory tract infection disappears after treatment Respiration 58 1991 176 180
58. M Nakanishi, K Yagawa, S Hayashi et al. Plasma thrombosis-inducing activity in 120 patients with primary lung cancer Oncology 48 1991 297 300
59. D Dreyfuss, F Leviel, M Paillard, J Rahmani, F Coste Acute infectious pneumonia is accompanied by a latent vasopressin-dependent impairment of renal water excretion Am Rev Respir Dis 138 1988 583 589
60. S Kruger, S Ewig, S Giersdorf, O Hartmann, N Suttorp, T Welte Cardiovascular and inflammatory biomarkers to predict short- and long-term survival in community-acquired pneumonia: results from the German Competence Network, CAPNETZ Am J Respir Crit Care Med 182 2010 1426 1434
61. SC Meijvis, MC Cornips, H Endeman et al. Prognostic value of serum angiotensin-converting enzyme activity for outcome of community-acquired pneumonia Clin Chem Lab Med 49 2011 1525 1532
62. EM van de Garde, H Endeman, VH Deneer et al. Angiotensin-converting enzyme (ACE) I/D corrected serum ACE activity and severity assessment of community-acquired pneumonia Clin Chem Lab Med 45 2007 1326 1331
63. EM van de Garde, H Endeman, VH Deneer et al. Angiotensin-converting enzyme insertion/deletion polymorphism and risk and outcome of pneumonia Chest 133 2008 220 225
64. R Murugan, V Karajala-Subramanyam, M Lee et al. Acute kidney injury in non-severe pneumonia is associated with an increased immune response and lower survival Kidney Int 77 2010 527 535
65. AR Akram, A Singanayagam, G Choudhury, P Mandal, JD Chalmers, AT Hill Incidence and prognostic implications of acute kidney injury on admission in patients with community-acquired pneumonia Chest 138 2010 825 832
66. C Vlachopoulos, I Dima, K Aznaouridis et al. Acute systemic inflammation increases arterial stiffness and decreases wave reflections in healthy individuals Circulation 112 2005 2193 2200
67. JA Chirinos, P Segers Noninvasive evaluation of left ventricular afterload: part 1: pressure and flow measurements and basic principles of wave conduction and reflection Hypertension 56 2010 555 562
68. JA Chirinos, P Segers Noninvasive evaluation of left ventricular afterload: part 2: arterial pressure-flow and pressure-volume relations in humans Hypertension 56 2010 563 570
69. O Ruuskanen, E Lahti, LC Jennings, DR Murdoch Viral pneumonia Lancet 377 2011 1264 1275
70. L Andreoletti, N Leveque, C Boulagnon, C Brasselet, P Fornes Viral causes of human myocarditis Arch Cardiovasc Dis 102 2009 559 568
71. CY Tong, F Potter, E Worthington, P Mullins Chlamydia pneumoniae myocarditis Lancet 346 1995 710 711
72. T Gandhi, AH Wu, DM Aronoff Severe transient cardiomyopathy associated with community-acquired pneumonia caused by Streptococcus pneumoniae Heart Lung 37 2008 394 397
73. F Haddad, G Berry, RL Doyle, P Martineau, TK Leung, N Racine Active bacterial myocarditis: a case report and review of the literature J Heart Lung Transplant 26 2007 745 749
74. KH Nelson, T Li, L Afonso Diagnostic approach and role of MRI in the assessment of acute myocarditis Cardiol Rev 17 2009 24 30
75. C Watson, NJ Alp Role of Chlamydia pneumoniae in atherosclerosis Clin Sci 114 2008 509 531
76. RB Light Pulmonary pathophysiology of pneumococcal pneumonia Semin Respir Infect 14 1999 218 226
77. A Modica, F Karlsson, T Mooe Platelet aggregation and aspirin non-responsiveness increase when an acute coronary syndrome is complicated by an infection J Thromb Haemost 5 2007 507 511
78. P Vallance, J Collier, K Bhagat Infection, inflammation, and infarction: does acute endothelial dysfunction provide a link? Lancet 349 1997 1391 1392
79. RJ Anderson Hospital-associated hyponatremia Kidney Int 29 1986 1237 1247
80. MJ Fine, TE Auble, DM Yealy et al. A prediction rule to identify low-risk patients with community-acquired pneumonia N Engl J Med 336 1997 243 250
81. PR Studdy, R Lapworth, R Bird Angiotensin-converting enzyme and its clinical significance - a review J Clin Pathol 36 1983 938 947
82. JD Chalmers, A Singanayagam, MP Murray, AT Hill Prior statin use is associated with improved outcomes in community-acquired pneumonia Am J Med 121 2008 1002 1007
83. J Winning, J Reichel, Y Eisenhut et al. Anti-platelet drugs and outcome in severe infection: clinical impact and underlying mechanisms Platelets 20 2009 50 57
84. RG Petersdorf, LE Cluff, PD Hoeprich, FT Hopkins, WP McCann Pneumoccocal pneumonia treated with penicillin and aspirin Bull Johns Hopkins Hosp 101 1957 1 12
85. VF Corrales-Medina, DM Musher Immunomodulatory agents in the treatment of community-acquired pneumonia: a systematic review J Infect 63 2011 187 199
86. S Janda, A Young, JM Fitzgerald, M Etminan, J Swiston The effect of statins on mortality from severe infections and sepsis: a systematic review and meta-analysis J Crit Care 25 2010 656.e7 656.22
87. SR Majumdar, FA McAlister, DT Eurich, RS Padwal, TJ Marrie Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort study BMJ 333 2006 999
88. S Yende, EB Milbrandt, JA Kellum et al. Understanding the potential role of statins in pneumonia and sepsis Crit Care Med 39 2011 1871 1878
89. EM Mortensen, MJ Pugh, LA Copeland et al. Impact of statins and angiotensin-converting enzyme inhibitors on mortality of subjects hospitalised with pneumonia Eur Respir J 31 2008 611 617
90. I Douglas, S Evans, L Smeeth Effect of statin treatment on short term mortality after pneumonia episode: cohort study BMJ 342 2011 d1642
91. SM Doshi, PA Kulkarni, JM Liao, DM Musher The impact of statin and macrolide use on early survival in patients with pneumococcal pneumonia Am J Med Sci 2012 10.1097/MAJ.0b013e3182639c26 published online Oct 29.
92. MB Rothberg, C Bigelow, PS Pekow, PK Lindenauer Association between statins given in hospital and mortality in pneumonia patients J Gen Intern Med 27 2012 280 286
93. EM Mortensen, MI Restrepo, A Anzueto, J Pugh The impact of prior outpatient ACE inhibitor use on 30-day mortality for patients hospitalized with community-acquired pneumonia BMC Pulm Med 5 2005 12
94. PR Myles, RB Hubbard, JE Gibson, Z Pogson, CJ Smith, TM McKeever The impact of statins, ACE inhibitors and gastric acid suppressants on pneumonia mortality in a UK general practice population cohort Pharmacoepidemiol Drug Saf 18 2009 697 703
95. EM Mortensen, MI Restrepo, LA Copeland, JA Pugh, A Anzueto Association of hydrophilic versus lipophilic angiotensin-converting enzyme inhibitor use on pneumonia-related mortality Am J Med Sci 336 2008 462 466
96. EM Mortensen, MI Restrepo, LA Copeland et al. Impact of previous statin and angiotensin II receptor blocker use on mortality in patients hospitalized with sepsis Pharmacotherapy 27 2007 1619 1626
97. WA Ray, KT Murray, K Hall, PG Arbogast, CM Stein Azithromycin and the risk of cardiovascular death N Engl J Med 366 2012 1881 1890
98. DP Healy, JV Sahai, SH Fuller, RE Polk Vancomycin-induced histamine release and "red man syndrome": comparison of 1- and 2-hour infusions Antimicrob Agents Chemother 34 1990 550 554
99. CL Renz, JD Thurn, HA Finn, JP Lynch, J Moss Antihistamine prophylaxis permits rapid vancomycin infusion Crit Care Med 27 1999 1732 1737
100. LS Cohen, AS Wechsler, JH Mitchell, G Glick Depression of cardiac function by streptomycin and other antimicrobial agents Am J Cardiol 26 1970 505 511